Aberrant expression of β-catenin, Pin1and cylin D1 in salivary adenoid cystic carcinoma: Relation to tumor proliferation and metastasis

Oncology Reports

Volumn 16, Issue 3, 2006, Pages 505-511

  Zhou, Chuan Xiang ^a   Gao, Yan ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

catenin; Cyclin D1; Immunohistochemistry; Pin1; RT PCR; Salivary adenoid cystic carcinomas; Western blot

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CELL PROLIFERATION; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR;

ADULT; AGED; BETA CATENIN; CARCINOMA, ADENOID CYSTIC; CELL PROLIFERATION; CYCLIN D1; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYLPROLYL ISOMERASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS;

EID: 33749183592     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ellis GL and Auclair PL: Adenoid cystic carcinoma. In: Atlas of Tumor Pathology. Third Series, Fascicle 17. Tumors of the Salivary Glands. Armed Forces Institute of Pathology, Washington, DC, pp203-216, 1996.
2. Wodarz A and Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88, 1998. (Pubitemid 29001449)
3. Behrens J, von Kries JP, Kuhl M, et al: Fuctional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642, 1996. (Pubitemid 26268958)
4. Shutman M, Zhurinsky J, Simcha I, et al: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999. (Pubitemid 29234650)
5. Fodde R, Smits R and Clevers H: APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1: 55-67, 2001. (Pubitemid 33741881)
6. Tsuchiya R, Yamamoto G, Nagochi Y, Aida T, Irie T and Tachikawa T: Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma. Oral Oncol 40: 932-940, 2004. (Pubitemid 39369566)
7. Neufeld KL, Zhang F, Cullen BR and White RL: APC-mediated down-regulation of β-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 1: 519-523, 2000.
8. Fujimori M, Ikeda S, Shimizu Y, Okajima M and Asahara T: Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor. Cancer Res 61: 6656-6659, 2001. (Pubitemid 32896480)
9. Koch A, Waha A, Tonn JC, et al: Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93: 445-449, 2001. (Pubitemid 32592067)
10. Moon RT, Bowerman B, Boutros M and Perrimon N: The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644-1646, 2002. (Pubitemid 34579151)
11. Lin SY, Xia W, Wang JC, et al: Beta-catenin, a novel prognostic marker for breast cancer:its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266, 2000. (Pubitemid 30226121)
12. Wulf GM, Ryo A, Wulf GG, et al : Pin1 is overexpressed in breast cancer and potentistes the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J 20: 3459-3472, 2001. (Pubitemid 32634353)
13. Ryo A, Liou YC, Lu KP and Wulf G: Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J Cell Sci 116: 773-783, 2003. (Pubitemid 36367627)
14. Ayala G, Wang D, Wulf G, et al: Pin1 is a novel prognostic marker in prostate cancer. Cancer Res 63: 6244-6251, 2003.
15. Pang R, John Y, Yuen MF, et al: Pin1 overexpression and β-catenin gene mutation are distinct oncogene events in human hepatocellular carcinoma. Oncogene 23: 4182-4186, 2004. (Pubitemid 38747951)
16. Ryo A, Nakamura M, Wulf G, Liou YC and Lu KP: Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801, 2001. (Pubitemid 32842684)
17. Daa T, Kashima K, Kaku N, Suzaki M and Yokoyama S: Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma. Modern Pathol 17: 1475-1482, 2004. (Pubitemid 39627073)
18. Barker N and Clevers H: Catenins, Wnt signaling and cancer. Bioessays 22: 961-965, 2000.
19. Peifer M and Polakis P: Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609, 2000. (Pubitemid 30127755)
20. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC Pathway. Science 281: 1509-1512, 1998. (Pubitemid 28425575)
21. Moreno-Bueno G, Hardisson D, Sanchez C, et al: Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21: 7981-7990, 2002. (Pubitemid 35430609)
22. Frierson HF Jr, El-Naggar AK, Welsh JB, et al: Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161: 1315-1323, 2002.
23. Huang J, Papadopoulos N, Mckinley AJ, et al: APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 93: 9049-9054, 1996. (Pubitemid 26282016)
24. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
25. Liu W, Dong X, Mai M, et al: Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26: 146-147, 2000.
26. Gerstein AV, Almeida TA, Zhao G, et al: APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34: 9-16, 2002. (Pubitemid 34260591)
27. Hajra KM and Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34: 255-268, 2002. (Pubitemid 34553304)
28. Taniguchi K, Roberts LR, Aderca IN, et al: Mutational spectrum of beta-catenin, AXIN1 and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21: 4863-4871, 2002. (Pubitemid 34879463)
29. Yokota N, Nishizawa S, Ohta S, et al: Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 101: 198-201, 2002. (Pubitemid 34970914)
30. Mizushima T, Nakagawa H, Kamberov YG, Wilder EL, Klein PS and Rustgi AK: Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res 62: 277-282, 2002. (Pubitemid 34074015)
31. Wang Z, Shu W, Lu MM and Morrisey EE: Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10 and LRP5. Mol Cell Biol 25: 5022-5030, 2005. (Pubitemid 40781102)
32. Mi K and Johnson GV: Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. Cell Biochem 95: 328-338, 2005. (Pubitemid 41420202)
33. Winkler KE, Swenson KI, Kornbluth S and Means AR: Requirement of the prolyl isomerase Pin1 for the replication check-point. Science 287: 1644-1647, 2000. (Pubitemid 30127764)
34. Yaffe MB, Schutkowski M, Shen M, et al: Sequence-specific and phosphorylation-dependent praline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957-1960, 1997. (Pubitemid 28013239)
35. Miyashita H, Mori S, Motegi K, Fukumoto M and Uchida T: Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep 10: 455-461, 2003.
36. Wulf G, Garg P, Liou YC, Iglehart D and Lu KP: Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 23: 3397-3407, 2004. (Pubitemid 39209163)
37. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP and Wang DG: Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164: 1727-1737, 2004. (Pubitemid 38529775)
38. Liou YC, Ryo A, Huang HK, et al: Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA 99: 1335-1340, 2002. (Pubitemid 34136494)
39. Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW and Lu KP: Pin1 is an E3F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 22: 5281-5295, 2002. (Pubitemid 34755742)